Ma, Q <br/><br/>
Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.  [electronic resource] 

 -  The pharmacogenomics journal  Dec 2007 
 - 386-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1470-269X 
<br/><br/><label>Standard No.: </label>10.1038/sj.tpj.6500433  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alcohol Oxidoreductases--genetics<br/>Anemia, Sickle Cell--blood<br/>Antisickling Agents--metabolism<br/>Arginase--genetics<br/>Biotransformation--genetics<br/>Chromosomes, Human, Pair 6<br/>Chromosomes, Human, Pair 8<br/>Double-Blind Method<br/>Erythropoiesis--genetics<br/>Fetal Hemoglobin--metabolism<br/>Genotype<br/>Humans<br/>Hydroxyurea--metabolism<br/>Linkage Disequilibrium<br/>Nitric Oxide Synthase Type I--genetics<br/>Phenotype<br/>Polymorphism, Single Nucleotide<br/>Severity of Illness Index<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>Vascular Endothelial Growth Factor Receptor-1--genetics